Osteoporosis International

Article	Citations
Hypercalcemia in non-Hodgkin’s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D	605
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	202
Letter to the editor regarding “Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening”	77
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	76
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts	76
World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Author Index	69
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	67
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	67
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	50
Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006–2022)	49
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	48
Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?	47
Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study	47
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	45
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	45
Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women	41
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ROS-IOF-ESCEO Symposium Abstracts	40
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	39
Return on investment of fracture liaison services: a systematic review and analysis	36
COVID pandemic and denosumab adherence	34
Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study	33
Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis	32
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	32
Cross-sectional associations between adipose tissue depots and areal bone mineral density in the UK Biobank imaging study	31
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	31

The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys	30
FRAX-based intervention thresholds for Pakistan	30
The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis	29
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	29
Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis	29
Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy	28
Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis	27
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts	27
A literature review to understand the burden of disease in people living with tumour-induced osteomalacia	27
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	26
The association between hyperkyphosis and fall incidence among community-dwelling older adults	26
Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies	25
Gender differences in osteoporosis	25
Bone density in youth with prediabetes: results from the National Health and Nutrition Examination Survey, 2005–2006	24
Sickle cell bone disease and response to intravenous bisphosphonates in children	24
Snyder-Robinson syndrome: differential diagnosis of osteogenesis imperfecta	24
Risk of developing age-related macular degeneration in patients with osteoporosis: a population-based, longitudinal follow-up study	23
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	23
Frailty, length of stay and cost in hip fracture patients	23
Loss of lower extremity bone mineral density 1 year after denosumab is discontinued in persons with subacute spinal cord injury	22
Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study	22
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	22
Response to: Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated	22
Safety of zoledronate in older patients at high risk of fracture with reduced renal function	21
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-control	21
Correction: The effects of biomechanical factors on adjacent vertebral compression fractures after percutaneous kyphoplasty: a propensity score matching analysis	21
Trabecular bone score in people with cystic fibrosis	21
Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury	20
Association with sagittal alignment and osteoporosis-related fractures in outpatient women with osteoporosis	20
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	20
Correction to: The clinician’s guide to prevention and treatment of osteoporosis	20
Appropriate dosing of burosumab in tumor-induced osteomalacia	20
Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients	19
Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis	19
Effect of pulmonary function on bone mineral density in the United States: results from the NHANES 2007–2010 study	19
Author response to letter to editor OSIN-D-23-00809: ALDH2 polymorphism rs671 and alcohol consumption: possible explanatory factors for race/ethnic differences in bone density	19
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	19
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture	18
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	18
Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease	18
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	18
Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism	18
Prunes preserve cortical density and estimated strength of the tibia in a 12-month randomized controlled trial in postmenopausal women: The Prune Study	17
Associations between ultra-distal forearm bone mineral density and incident fracture in women	17
Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017–2019	17
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	17
Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial	17
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	17
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	17
Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures	17

Correction to: Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	16
Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta	16
Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	16
Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service	16
Association of depressive symptoms with incident fractures: the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT)	16
Osteoporosis and fracture risk assessment in adults with ischaemic stroke	16
Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthr	16
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	16
Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk”	15
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	15
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	15
Prevalence of low vitamin D levels among older US Asian and Pacific Islander adults	15
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	15
The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials	15
Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients	15
Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures	15
Diagnostic accuracy of artificial intelligence models in detecting osteoporosis using dental images: a systematic review and meta-analysis	15
One versus 2 years of alendronate following denosumab: the CARD extension	15
First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities	14
Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report	14
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	14
Association of standardized serum 25-hydroxyvitamin D with falls in post-menopausal women	14
A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women	14
Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan	14
Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study	14
Examining effects of habitual physical activity and body composition on bone structure in early post-menopausal women: a pQCT analysis	13
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture	13
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis	13
Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review	13
Trends in fractures in patients with spondyloarthritis: a nationwide population-based study (TREND-EspA study)	13
Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.	13
Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study	13
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	13
Effect of postural alignment alteration with age on vertebral strength	13
The pattern of incident fractures according to fracture site in people with T1D	13
Is it important to achieve physical activity recommendations at early stages of life to improve bone health?	13
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	13
Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries	13
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data	13
Detecting hip osteoarthritis on clinical CT: a deep learning application based on 2-D summation images derived from CT	13
Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis	13
A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study	12
Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up	12
Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia	12
Association of C-peptide level with bone mineral density in type 2 diabetes mellitus	12
Osteoporosis medication adherence tools: a systematic review	12
Response letter to: “The importance of structural barriers of osteoporotic hip fracture in the elderly”	12
Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis	12
Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene	12
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study	12
Correction: Is dual-energy absorptiometry accurate in the assessment of bone status of patients with chronic kidney disease?	12
The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures	12
Correction: Vitamin D status and clinical implications in the adult population of Malaysia: a position paper by the Malaysian Vitamin D Special Interest Group	12
Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography	12
The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study	12
Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis	12
Factors besides frailty index affect length of stay in older patients with hip fractures	12
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise	12
Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden	11
External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans	11
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	11
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	11
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study	11
The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scienti	11
Management of osteoporosis in patients with chronic kidney disease	11
Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: a Mendelian randomization study	11
Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology	11
Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials	11
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	11
The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty	11
Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asi	11
Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study	11
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	11
Clinical experience with denosumab discontinuation	11
Cross-sectional studies of the causal link between asthma and osteoporosis: insights from Mendelian randomization and bioinformatics analysis	11
An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study	11
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	11
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study	11
Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older	11
Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis	11

A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Tri	10
Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis	10
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	10
Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators	10
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX	10
Health-related quality of life of patients with a recent fracture attending a fracture liaison service: a 3-year follow-up study	10
Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer	10
Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis	10
PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	10
RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans	10
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts	10
Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis	10
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture	10
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	10
Pharmacist interventions in osteoporosis management: a systematic review	10
Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report	10
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	9
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	9
Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study	9
Association between body mass index, bone bending strength, and BMD in young sedentary women	9
Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial	9
Fracture liaison services in Ireland—how do we compare to international standards?	9
Author response to letter to editor: OSIN-D-23–00474, “letter to the editor regarding ‘Opportunistic use of lumbar magnetic resonance imaging for osteoporosis screening’”	9
Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging	9
The influence of iron on bone metabolism disorders	9
Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study	9
Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	9
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	9
Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample	9
Meta-analyses of the quantitative computed tomography data in dialysis patients show differential impacts of renal failure on the trabecular and cortical bones	9
Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study	9
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	9
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption	9
The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study	9
Gamma-glutamyl-transferase is associated with incident hip fractures in women and men ≥ 50 years: a large population-based cohort study	9
A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification	9
Denosumab is not associated with risk of malignancy? More evidence is needed	9
IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts	9
Correction: Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions	9
Height loss in postmenopausal women—do we need more for fracture risk assessment? Results from the GO Study	9
Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit	9
Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case–control study with a mean 7-year follow-up	9
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	8
Hip fractures in patients with primary aldosteronism – a Swedish nationwide study	8
The yield of routine laboratory examination in osteoporosis evaluation in primary care	8
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	8
Publisher Correction: A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration	8
Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?	8
Effect of testosterone treatment on the trabecular bone score in older men with low serum testosterone	8
Internal medicine inpatients’ prevalence of misdiagnosed severe osteoporosis	8
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	8
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	8
Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications	8
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	8
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment	8
Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures	8
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	8
Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals	8
Long-term effects of lifestyle and metformin interventions in DPP on bone density	8
Analysis of the effects of a delay of surgery in patients with hip fractures: outcome and causes	8
Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study	8
Regular physical activity improves physical function and health-related quality of life among middle-aged and older women who suffered a fragility fracture—a population-based cohort	8
Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study	8
IOF position on scientists and societies operating in conflict zones	8
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	8
Fracture risk assessment in the presence of competing risk of death	8
Clinical use of melatonin in osteoporosis: Expectations still unmet	8
One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD	8
Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	8
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	8
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	8
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	8
Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawaiʻi: higher mortality risk among Native Hawaiians and other Pacific Islanders	8
Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia	7
Bisphosphonate holidays: using cost-effectiveness analysis for the “yes, but” questions	7
Osteoporotic vertebral endplate and/or cortex fracture is not always radiographically detectable	7
Effect of standing frames used in real life on bone remodeling in non-walking children with cerebral palsy	7
Retrospective analyses of clinical features in 28 Chinese patients with type V osteogenesis imperfecta: new perspectives in an old issue	7
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	7
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study	7
Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis	7
Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study	7
Letter of response to Professor Dalgleish regarding our paper Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a	7
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family	7
Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis	7
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort s	7
Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service	7
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS	7
Zoledronic acid and bone health in older adults with cognitive impairment	7
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up	7
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair	7
Trabecular bone score and its association with Cobb angle kyphosis in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) Study	7
Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018	7
Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review	7
Is repeated childhood fracture related to areal bone density or body composition in middle age?	7